Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CVS HEALTH Corp
Report date February 28, 2021 · Filed March 02, 2021
Section 16 reporting ended · disclosed 2021-03-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,656.958 |
Reported balance
After 2021-02-28 transaction · row 1
1 source rowRow 1 · 2021-02-28 · Tax withholding · Disposed 572 · Balance 25,656.958 F1: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2021 Filed Mar 2, 2021 21:59 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 572 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-008773 · form4.xml · nonDerivative · entry 1 Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,656.958 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 21:16 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 21,460 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-20-028784 · form4.xml · derivative · entry 4 Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,460 shares Expires 2021-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options became exercisable in three equal annual installments beginning on 4/1/2014. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 21:16 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 21,460 | $70.00 | $1,502,200.00 |
DisclosureSEC source: 0001127602-20-028784 · form4.xml · nonDerivative · entry 2 Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000.958 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 21:16 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 21,460 | $34.96 | $750,241.60 |
DisclosureSEC source: 0001127602-20-028784 · form4.xml · nonDerivative · entry 1 Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,460.958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 63,358 | $58.61 Strike: $58.61 | $3,713,412.38 |
DisclosureSEC source: 0001127602-20-013235 · form4.xml · derivative · entry 3 Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,358 Underlying: Common Stock · 63,358 shares Expires 2030-04-01 F2 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price. F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2021. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 973 | $58.34 | $56,764.82 |
DisclosureSEC source: 0001127602-20-013235 · form4.xml · nonDerivative · entry 1 Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000.958 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2020 Filed Apr 7, 2020 21:40 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 63,358 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0001127602-20-013412 · form4a.xml · derivative · entry 1 Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,358 Underlying: Common Stock · 63,358 shares Expires 2030-04-01 F1 · derivative.exercise_price: This Form 4/A is being filed in order to correct the exercise price (Table II, column 2) for the stock option granted on 4/1/2020, which was reported incorrectly on the original Form 4 due to a clerical error. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 1 | $59.18 | $59.18 |
DisclosureSEC source: 0001127602-20-009163 · form4.xml · nonDerivative · entry 4 Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,691 F3 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 28, 2021. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,026 | $59.18 | $60,718.68 |
DisclosureSEC source: 0001127602-20-009163 · form4.xml · nonDerivative · entry 3 Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,827.958 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of stock awards under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 3,379 | $59.18 | $199,969.22 |
DisclosureSEC source: 0001127602-20-009163 · form4.xml · nonDerivative · entry 2 Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,853.958 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 498 | $59.18 | $29,471.64 |
DisclosureSEC source: 0001127602-20-009163 · form4.xml · nonDerivative · entry 1 Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,474.958 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 22:17 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 844 | $59.33 | $50,074.52 |
DisclosureSEC source: 0001127602-20-008398 · form4.xml · nonDerivative · entry 1 Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,338.958 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 21:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 17,703 | $0.00 Strike: $54.53 | $0.00 |
DisclosureSEC source: 0001127602-19-029433 · form4.xml · derivative · entry 5 Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,703 shares Expires 2020-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options became exercisable in four equal annual installments beginning on 4/1/2014. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 21:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 17,703 | $63.00 | $1,115,289.00 |
DisclosureSEC source: 0001127602-19-029433 · form4.xml · nonDerivative · entry 2 Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,460 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 21:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 17,703 | $54.53 | $965,344.59 |
DisclosureSEC source: 0001127602-19-029433 · form4.xml · nonDerivative · entry 1 Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,163 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:59 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 60,602 | $54.19 Strike: $54.19 | $3,284,022.38 |
DisclosureSEC source: 0001127602-19-014678 · form4.xml · derivative · entry 4 Flum Joshua Matthew · CIK 0001412223 · EVP, Corp Strategy & Bus Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,602 Underlying: Common Stock · 60,602 shares Expires 2029-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2020. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:59 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 742 | $54.19 | $40,208.98 |
DisclosureSEC source: 0001127602-19-014678 · form4.xml · nonDerivative · entry 1 Flum Joshua Matthew · CIK 0001412223 · EVP, Corp Strategy & Bus Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,460 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan. Read SEC document |
| April 01, 2019 Filed Apr 12, 2019 21:15 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 60,602 | $54.19 Strike: $54.19 | $3,284,022.38 |
DisclosureSEC source: 0000947871-19-000286 · ownership.xml · derivative · entry 4 Flum Joshua Matthew · CIK 0001412223 · EVP, Ent. Strategy & Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,602 Underlying: Common Stock · 60,602 shares Expires 2029-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2020. Read SEC document |
| April 01, 2019 Filed Apr 12, 2019 21:15 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 742 | $54.19 | $40,208.98 |
DisclosureSEC source: 0000947871-19-000286 · ownership.xml · nonDerivative · entry 1 Flum Joshua Matthew · CIK 0001412223 · EVP, Ent. Strategy & Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,460 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 2,297 | $57.83 | $132,835.51 |
DisclosureSEC source: 0001127602-19-009281 · form4.xml · nonDerivative · entry 3 Flum Joshua Matthew · CIK 0001412223 · EVP, Corp Strategy & Bus Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,768 F3 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan and its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 28, 2020. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,268 | $57.83 | $73,328.44 |
DisclosureSEC source: 0001127602-19-009281 · form4.xml · nonDerivative · entry 2 Flum Joshua Matthew · CIK 0001412223 · EVP, Corp Strategy & Bus Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,214 F2 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 990 | $57.83 | $57,251.70 |
DisclosureSEC source: 0001127602-19-009281 · form4.xml · nonDerivative · entry 1 Flum Joshua Matthew · CIK 0001412223 · EVP, Corp Strategy & Bus Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,946 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2019 Filed Apr 12, 2019 21:10 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 2,297 | $57.83 | $132,835.51 |
DisclosureSEC source: 0000947871-19-000285 · ownership.xml · nonDerivative · entry 3 Flum Joshua Matthew · CIK 0001412223 · EVP, Ent. Strategy & Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,768 F3 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan and its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 28, 2020. Read SEC document |
| February 28, 2019 Filed Apr 12, 2019 21:10 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,268 | $57.83 | $73,328.44 |
DisclosureSEC source: 0000947871-19-000285 · ownership.xml · nonDerivative · entry 2 Flum Joshua Matthew · CIK 0001412223 · EVP, Ent. Strategy & Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,214 F2 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2019 Filed Apr 12, 2019 21:10 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 990 | $57.83 | $57,251.70 |
DisclosureSEC source: 0000947871-19-000285 · ownership.xml · nonDerivative · entry 1 Flum Joshua Matthew · CIK 0001412223 · EVP, Ent. Strategy & Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,946 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.